Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AMGN | GILD | CELG | ILMN |
| Company | Sarepta Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 127.53 | 265.72 | 65.50 | 108.01 | 119.65 |
| High | 131.46 | 271.68 | 66.35 | 108.59 | 123.73 |
| Low | 125.62 | 265.72 | 64.63 | 107.27 | 118.97 |
| Last | 128.77 | 269.98 | 65.42 | 108.24 | 122.28 |
| Change | +1.38 | +0.60 | +0.15 | +0.11 | +1.23 |
| % Change | +1.08% | +0.22% | +0.23% | +0.10% | +1.02% |
| Volume | 1,236,000 | 2,436,947 | 12,380,518 | 191,230,496 | 829,310 |
| 20-Day Average Volume | 747,475 | 2,156,942 | 7,062,296 | 16,188,930 | 1,511,671 |
| Previous Close | 127.39 | 269.38 | 65.27 | 108.13 | 121.05 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 123.07 | 269.99 | 68.29 | 108.17 | 124.88 |
| 20-Day Raw Stochastic | 84.26% | 40.03% | 9.20% | 63.25% | 28.73% |
| 20-Day Relative Strength | 58.26% | 45.47% | 29.21% | 64.69% | 43.55% |
| Weighted Alpha | +21.17 | +9.45 | -23.49 | +46.30 | -37.70 |
| Today's Opinion | 88% Buy | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 80% Buy | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 40% Buy | 88% Sell | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.37% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | -1.97% since 11/13/19 | +4.13% since 04/19/24 |
| Low | 114.48 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 116.91 on 04/25/24 |
| High | 131.46 on 04/26/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | +0.41% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | +5.14% since 10/18/19 | -8.61% since 03/26/24 |
| Low | 114.37 on 04/19/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 131.46 on 04/26/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +8.46% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | +13.63% since 08/20/19 | -13.05% since 01/26/24 |
| Low | 114.37 on 04/19/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 143.00 on 02/16/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +15.39% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +14.14% since 05/20/19 | +9.54% since 10/26/23 |
| Low | 55.25 on 10/31/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 143.00 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,961,921 | 144,488,960 | 81,266,176 | 77,035,920 | 19,277,818 |
| Shares Outstanding, K | 93,900 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 1,243,340,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -535,980,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 396,780,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 45,650,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.94 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 02/28/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 141.23 |